JP2014520787A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520787A5 JP2014520787A5 JP2014517822A JP2014517822A JP2014520787A5 JP 2014520787 A5 JP2014520787 A5 JP 2014520787A5 JP 2014517822 A JP2014517822 A JP 2014517822A JP 2014517822 A JP2014517822 A JP 2014517822A JP 2014520787 A5 JP2014520787 A5 JP 2014520787A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11173067 | 2011-07-07 | ||
| EP11173067.7 | 2011-07-07 | ||
| PCT/EP2012/063249 WO2013004818A1 (en) | 2011-07-07 | 2012-07-06 | Darunavir combination formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520787A JP2014520787A (ja) | 2014-08-25 |
| JP2014520787A5 true JP2014520787A5 (enExample) | 2015-08-13 |
| JP6122427B2 JP6122427B2 (ja) | 2017-04-26 |
Family
ID=46551505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517822A Active JP6122427B2 (ja) | 2011-07-07 | 2012-07-06 | ダルナビル複合製剤 |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20140142070A1 (enExample) |
| EP (1) | EP2729130B1 (enExample) |
| JP (1) | JP6122427B2 (enExample) |
| KR (1) | KR102058097B1 (enExample) |
| CN (1) | CN103826616B (enExample) |
| AU (1) | AU2012280198B2 (enExample) |
| BR (1) | BR112014000290B1 (enExample) |
| CA (1) | CA2838659C (enExample) |
| CY (1) | CY1121999T1 (enExample) |
| DK (1) | DK2729130T3 (enExample) |
| EA (1) | EA026587B1 (enExample) |
| ES (1) | ES2651212T3 (enExample) |
| HR (1) | HRP20171889T1 (enExample) |
| HU (1) | HUE035241T2 (enExample) |
| IL (1) | IL229933A (enExample) |
| LT (1) | LT2729130T (enExample) |
| MX (1) | MX343689B (enExample) |
| NO (1) | NO2729130T3 (enExample) |
| PL (1) | PL2729130T3 (enExample) |
| PT (1) | PT2729130T (enExample) |
| RS (1) | RS56667B1 (enExample) |
| SI (1) | SI2729130T1 (enExample) |
| SM (1) | SMT201700574T1 (enExample) |
| WO (1) | WO2013004818A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140142070A1 (en) | 2011-07-07 | 2014-05-22 | Janssen R&D Ireland | Darunavir combination formulations |
| JP2015508822A (ja) * | 2012-03-01 | 2015-03-23 | ギリアード サイエンシーズ， インコーポレイテッド | 噴霧乾燥製剤 |
| DK3067358T3 (da) | 2012-12-21 | 2019-11-04 | Gilead Sciences Inc | Polycykliske carbamoylpyridon-forbindelser og deres farmaceutiske anvendelse |
| SI3346995T1 (sl) | 2015-11-09 | 2019-11-29 | Gilead Sciences Inc | Terapevtski sestavek za zdravljenje virusa človeške imunske pomanjkljivosti |
| WO2018029566A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | A high drug loaded tablet composition for treating hiv |
| ES2952878T3 (es) * | 2016-08-08 | 2023-11-06 | Hetero Labs Ltd | Una composición antirretroviral multiclase |
| EP3496718A4 (en) | 2016-08-08 | 2020-01-22 | Hetero Labs Limited | ANTIRETROVIRAL COMPOSITIONS |
| EP3518935A1 (en) * | 2016-09-27 | 2019-08-07 | Gilead Sciences, Inc. | Therapeutic compositions for treatment of human immunodeficiency virus |
| BR112020000842A2 (pt) | 2017-07-20 | 2020-07-21 | Janssen Sciences Ireland Unlimited Company | composições e métodos para tratamento do hiv |
| WO2020064980A1 (en) | 2018-09-28 | 2020-04-02 | Janssen Sciences Ireland Unlimited Company | Methods of treating and preventing neuropsychiatric and/or neurocognitive complications in patients infected with hiv |
| WO2021180963A1 (en) | 2020-03-13 | 2021-09-16 | Janssen Sciences Ireland Unlimited Company | A protease inhibitor regimen for treating subjects infected with hiv |
| CN119700779B (zh) * | 2024-11-28 | 2025-11-04 | 安徽贝克生物制药有限公司 | 一种达芦那韦和考比司他复合片剂及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968942A (en) | 1992-08-25 | 1999-10-19 | G. D. Searle & Co. | α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| DK0715618T3 (da) | 1993-08-24 | 1999-08-23 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
| PT2336134T (pt) | 1998-06-23 | 2016-10-19 | The Board Of Trustees Of The Univ Of Illionis | Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia |
| AR037797A1 (es) | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| JP4864320B2 (ja) | 2002-05-16 | 2012-02-01 | テイボテク・フアーマシユーチカルズ・リミテツド | Ｈｉｖプロテアーゼ阻害剤の疑似多形相 |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| JP5285603B2 (ja) | 2006-05-30 | 2013-09-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒスタミンｈ３受容体のモジュレーターとしての置換ピリジルアミド化合物 |
| US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
| AR061838A1 (es) | 2006-07-07 | 2008-09-24 | Gilead Sciences Inc | Moduladores de propiedades farmacocineticas de terapeuticos |
| US20080113021A1 (en) * | 2006-10-25 | 2008-05-15 | Robert Shen | Ibuprofen composition |
| TWI533868B (zh) | 2007-02-23 | 2016-05-21 | 吉李德科學股份有限公司 | 治療劑藥物動力學性質之調節劑 |
| AU2008267237A1 (en) * | 2007-06-25 | 2008-12-31 | Tibotec Pharmaceuticals | Combination formulations comprising darunavir and etravirine |
| AR069539A1 (es) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | Avances respecto de las formulaciones de comprimidos contra el vih |
| MY158253A (en) | 2007-11-20 | 2016-09-30 | Janssen Pharmaceutica Nv | Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| PA8809601A1 (es) * | 2007-12-24 | 2009-07-23 | Cipla Ltd | Combinación anti-retroviral |
| SG10201609006WA (en) * | 2008-05-02 | 2016-12-29 | Gilead Sciences Inc | The use of solid carrier particles to improve the processability of a pharmaceutical agent |
| US20100285122A1 (en) * | 2009-02-06 | 2010-11-11 | Gilead Sciences, Inc. | Tablets for combination therapy |
| PL2477992T3 (pl) * | 2009-09-17 | 2017-07-31 | Mylan Laboratories Limited | Proces przygotowania Darunawiru i jego amorficznych postaci |
| ES2699183T3 (es) | 2010-05-10 | 2019-02-07 | Hetero Research Foundation | Composiciones de darunavir |
| DK2729128T3 (en) | 2011-07-07 | 2016-11-21 | Janssen Sciences Ireland Uc | Darunavir-FORMULATIONS |
| US20140142070A1 (en) | 2011-07-07 | 2014-05-22 | Janssen R&D Ireland | Darunavir combination formulations |
| AU2012327170A1 (en) | 2012-02-03 | 2013-08-22 | Gilead Sciences, Inc. | Therapeutic compounds |
| US20170348334A1 (en) | 2015-01-03 | 2017-12-07 | Mylan Laboratories Limited | Processes for the preparation of amorphous tenofovir alafenamide hemifumarate and a premix thereof |
-
2012
- 2012-07-06 US US14/131,282 patent/US20140142070A1/en not_active Abandoned
- 2012-07-06 HU HUE12738060A patent/HUE035241T2/en unknown
- 2012-07-06 ES ES12738060.8T patent/ES2651212T3/es active Active
- 2012-07-06 DK DK12738060.8T patent/DK2729130T3/en active
- 2012-07-06 MX MX2013015199A patent/MX343689B/es active IP Right Grant
- 2012-07-06 RS RS20171244A patent/RS56667B1/sr unknown
- 2012-07-06 SI SI201231141T patent/SI2729130T1/en unknown
- 2012-07-06 NO NO12738060A patent/NO2729130T3/no unknown
- 2012-07-06 CA CA2838659A patent/CA2838659C/en active Active
- 2012-07-06 EA EA201490222A patent/EA026587B1/ru unknown
- 2012-07-06 JP JP2014517822A patent/JP6122427B2/ja active Active
- 2012-07-06 SM SM20170574T patent/SMT201700574T1/it unknown
- 2012-07-06 KR KR1020147000092A patent/KR102058097B1/ko active Active
- 2012-07-06 PL PL12738060T patent/PL2729130T3/pl unknown
- 2012-07-06 PT PT127380608T patent/PT2729130T/pt unknown
- 2012-07-06 HR HRP20171889TT patent/HRP20171889T1/hr unknown
- 2012-07-06 WO PCT/EP2012/063249 patent/WO2013004818A1/en not_active Ceased
- 2012-07-06 AU AU2012280198A patent/AU2012280198B2/en active Active
- 2012-07-06 CN CN201280033554.0A patent/CN103826616B/zh active Active
- 2012-07-06 LT LTEP12738060.8T patent/LT2729130T/lt unknown
- 2012-07-06 BR BR112014000290-8A patent/BR112014000290B1/pt active IP Right Grant
- 2012-07-06 EP EP12738060.8A patent/EP2729130B1/en active Active
-
2013
- 2013-12-17 IL IL229933A patent/IL229933A/en active IP Right Grant
-
2017
- 2017-12-05 CY CY20171101267T patent/CY1121999T1/el unknown
-
2019
- 2019-11-27 US US16/697,888 patent/US11654150B2/en active Active
-
2023
- 2023-05-05 US US18/313,266 patent/US20230302024A1/en active Pending